Biolase Inc (BIOL):企業の財務・戦略的SWOT分析

◆英語タイトル:Biolase Inc (BIOL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME81FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biolase Inc (BIOL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. The company offers two categories of laser systems: WaterLase all tissue laser systems and Diode soft tissue laser systems. The Waterlase laser system product includes Waterlase Express, Waterlase iPlus and Waterlase MD and MDX; Diode system product includes e Epic Hygiene, Epic Pro, Epic X and Epic 10. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontist, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance services. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.

Biolase Inc Key Recent Developments

Nov 12,2020: BIOLASE reports strong sequential revenue growth in third quarter 2020
Oct 14,2020: BIOLASE announces preliminary third quarter revenue results; reopening of dental practices drives sequential revenue growth
Aug 13,2020: BIOLASE reports second quarter 2020 financial results
Jul 13,2020: Landmark Head-to-Head study published in Journal of Periodontology concludes that BIOLASE REPAIR Perio Protocol is superior for procedure time and patient-reported outcomes
May 07,2020: BIOLASE reports first quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biolase Inc – Key Facts
Biolase Inc – Key Employees
Biolase Inc – Key Employee Biographies
Biolase Inc – Major Products and Services
Biolase Inc – History
Biolase Inc – Company Statement
Biolase Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Biolase Inc – Business Description
Business Segment: Consumables and other
Overview
Performance
Business Segment: Imaging systems
Performance
Business Segment: Laser Systems
Overview
Performance
Key Stats
Business Segment: License fees and royalties
Overview
Performance
Business Segment: Services
Overview
Performance
Geographical Segment: International
Performance
Geographical Segment: The US
Performance
R&D Overview
Biolase Inc – Corporate Strategy
Biolase Inc – SWOT Analysis
SWOT Analysis – Overview
Biolase Inc – Strengths
Biolase Inc – Weaknesses
Biolase Inc – Opportunities
Biolase Inc – Threats
Biolase Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biolase Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Biolase Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Biolase Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2020: BIOLASE reports strong sequential revenue growth in third quarter 2020
Oct 14, 2020: BIOLASE announces preliminary third quarter revenue results; reopening of dental practices drives sequential revenue growth
Aug 13, 2020: BIOLASE reports second quarter 2020 financial results
Jul 13, 2020: Landmark Head-to-Head study published in Journal of Periodontology concludes that BIOLASE REPAIR Perio Protocol is superior for procedure time and patient-reported outcomes
May 07, 2020: BIOLASE reports first quarter 2020 financial results
Apr 14, 2020: Biolase receives loan under Paycheck Protection Program
Mar 26, 2020: BIOLASE reports 2019 fourth quarter; net revenue increased 18% sequentially
Nov 15, 2019: BIOLASE appoints Michael DiTolla, DDS, FAGD to its Board Of Directors
Nov 06, 2019: BIOLASE reports third quarter 2019 results
Oct 23, 2019: BIOLASE wraps inaugural advancing dentistry symposium
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biolase Inc, Key Facts
Biolase Inc, Key Employees
Biolase Inc, Key Employee Biographies
Biolase Inc, Major Products and Services
Biolase Inc, History
Biolase Inc, Subsidiaries
Biolase Inc, Key Competitors
Biolase Inc, Ratios based on current share price
Biolase Inc, Annual Ratios
Biolase Inc, Annual Ratios (Cont...1)
Biolase Inc, Interim Ratios
Biolase Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Biolase Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Biolase Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Biolase Inc (BIOL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Housing Bank for Trade and Finance:企業の戦略・SWOT・財務分析
    The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report Summary The Housing Bank for Trade and Finance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Saracen Mineral Holdings Ltd:企業の戦略・SWOT・財務分析
    Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • United Spirits Ltd:企業のM&A・事業提携・投資動向
    United Spirits Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Spirits Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • Dentsply Sirona Inc (XRAY):医療機器:M&Aディール及び事業提携情報
    Summary Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, is a medical device company that designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic in …
  • iBio Inc (IBIO)-製薬・医療分野:企業M&A・提携分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, …
  • China Eastern Airlines Corporation Limited:企業のM&A・事業提携・投資動向
    China Eastern Airlines Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Eastern Airlines Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Tabcorp Holdings Limited (TAH):企業の財務・戦略的SWOT分析
    Tabcorp Holdings Limited (TAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • XState Resources Ltd (XST):企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Consolidated Edison Inc (ED)-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research …
  • Olympic Mountain and Marine Products, Inc.:企業の戦略・SWOT・財務情報
    Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Taurus International MFG, Inc.:企業の戦略・SWOT・財務情報
    Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report Summary Taurus International MFG, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Terumo Corp (4543):企業の製品パイプライン分析2018
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • Kelly Services Inc (KELYA):企業の財務・戦略的SWOT分析
    Kelly Services Inc (KELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆